Investor Type | Firm |
Industries | Education • BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Early, Seed, Series A, Series B |
Investing | United States • France |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
T1D Fund is an early-stage venture capital investment fund launched by JDRF, to catalyze the development of commercial type 1 diabetes therapies. The goal of the JDRF T1D Fund is to make the case to donors and to venture, corporate and foundation capital sources that investment opportunities with high impact exist in the T1D space.